Houston-Based SynBio VC Firm Grows Advisory Team with Two New Experts
Retrieved on:
Tuesday, April 5, 2022
Coker, Synthetic biology, Patient, University of Arkansas for Medical Sciences, MD–PhD, Brown University, Biotechnology, Doctor of Philosophy, University of Central Arkansas, Medicine, CEO, Cocker, Entrepreneurship, Industry, Technology, VC, Veronica, Time, Host, Acceleration, Proxima, Central Arkansas, University, Moses Austin, Case Western Reserve University, Pharmaceutical industry, Pathology, Biology
These two advisors are experts in their respective fields of medicine and biotechnology.
Key Points:
- These two advisors are experts in their respective fields of medicine and biotechnology.
- As a physician-scientist, Gaurab took an oath to first do no harmand for him, that goes beyond patients or medicine.
- In 2016, he started Solugen to decarbonize the chemicals industry, one of the most damaging for people and the Earth.
- Chakrabarti believes in using biology in unconventional ways to solve incredibly complex problems and is building a world-class team to join him on the journey.